For example, demethylation of the MDR1 promoter and enhanced glycolysis have been implicated in the adaptive responses of tumor cells to ERK pathway inhibition (Huang et al., 2023[55]; Gaghan et al., 2024[33]). This evidence concerns the gene MAPK1 and neoplasm.